Short Chain Acyl Co-A Dehydrogenase Deficiency A Rare Inborn Error Of Metabolism
Short Chain Acyl Co-A Dehydrogenase Deficiency
Keywords:
SCADD, fatty acid oxidation, inborn errors of metabolismAbstract
recessive inborn error of mitochondrial fatty acid β oxidation. The energy producing fatty acid oxidation pathway is affected at the first step due to deficiency of short chain acyl coA dehydrogenase and is manifested as lethargy, metabolic acidosis and hypoglycaemia. We report a case ofeight day old male neonate born to 32 year old female by caesarean delivery diagnosed with SCADD. Investigations: Blood investigations of haematology, serum electrolytes, and enzymes levels were done. Metabolic screening for TSH, galactosaemia, blood ammonia was also conducted. Results: Serum sample revealed elevated acyl carnitine levels and urine analysis for organic acid showed slightly elevated Methyl malonic acid. The neonate was mechanically ventilated and metabolic acidosis was corrected with 8.4 % sodium bicarbonate andintravenous dextrose. Carnitor syrup 5ml/500mg was started once daily and the neonate improved in general activity along with weight gain. Conclusion: Neonatal screening by biochemical method facilitates earlier diagnosis and, along with effective management prevents morbidity and prolongs survival.
References
2. Jethva R, Bennett M.J, Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency. Molecular Genetics & Metabolism 2008; 95:195-200.
3. Nagao M, Tanaka K. FAD-dependent regulation of transcription, translation, post-translational processing, and post-processing stability of various mitochondrial acyl-CoA dehydrogenases and of electron transfer flavoprotein and the site of holoenzyme formation. J BiolChem 1992; 267:17925-32.
4. Corydon MJ, Gregersen N, Lehnert W, Ribes A, Rinaldo P, Kmoch S. Ethylmalonicaciduria is associated with an amino acid variant of short-chain acyl-coenzyme A dehydrogenase. Pediatr Res 1996; 39:1059-66.
5. vanMaldegem BT, Wanders RJ, Wijburg FA. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2010; 33:507-11.
6. Gordon N. Acyl-CoA dehydrogenase deficiency: varieties with neurologicalinvolvement. Developmental Medicine & Child Neurology 2005; 47;207-10.
7. Iafolla AK, Thompson RJ Jr, Roe CR. Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994; 124:409-15.
8. Gallant NM, Leydiker K, Tang H, Feuchtbaum L, Lorey F, Puckett R, et al. Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. Mol Genet Metab 2012; 106:55-61.
9. Nagan N, Kruckeberg KE, Tauscher AL, Bailey KS, Rinaldo P, Matern D.The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with theC(4)-acylcarnitine concentration in newborn blood spots. Mol Genet Metab 2003; 78:239-46.
10. Haas M, Chaplin M, Joy P, Wiley V, Black C, Wilcken B. Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening. Journal of Pediatrics 2007; 151:121-6.
